INSIGHTS ON CLINICAL TRIAL DESIGN

• How To Improve Patient Outcomes Using eSource Software In Clinical Trials

  As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.

• Assessing Diversity In Early-Phase Clinical Trials In A Rapidly Changing Regulatory Environment

  Learn more about structuring early-phase trials to address population variation and the contributing factors to safe drug administration, both of which are essential to a drug development plan.

• We Can Fix What's Broken in Research—If We Solve the Right Problems

  Addressing the root causes of inefficiencies in research is the only way to drive meaningful progress. Explore why tackling the right issues is essential to fixing broken research process.

• Pioneering Strategies For Early-Phase Oncology Trials

  As the field advances, adaptive methodologies and regulatory shifts redefine early-phase oncology trials, promoting efficiency, flexibility, and equitable access.

• Designing More Representative Trials Through Strategic Planning

  5/28/2025

  Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.

• The Patient Recruitment Shift: Navigating Disruption, Delivering Precision

  3/27/2025

  Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.

• Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data

  9/15/2025

  New, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.

• A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data

  2/25/2025

  Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

• Your Biggest Unblinding Risk? Inexperienced Staff

  4/28/2026

  Protect study integrity by closing the gaps in IRT workflows. Learn why rushed communication and training lapses lead to accidental unblinding and how to safeguard your clinical data.